Gastric DysmotilitySymptoms, Doctors, Treatments, Advances & More
Gastric Dysmotility Overview
Learn About Gastric Dysmotility
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Eagle Telemedicine- Gastroenterology
. Dr. Korenblit is rated as a Distinguished provider by MediFind in the treatment of Gastric Dysmotility. His top areas of expertise are Choledocholithiasis, Gastric Dysmotility, Barrett Esophagus, Endoscopy, and Gastrectomy.
Texas Health Digestive Specialists
"Dr. Aamer Agha has been performing colonoscopy, upper endoscopy and capsule endoscopy procedures since 2005. He is board certified in Gastroenterology and Internal Medicine. After graduating summa cum laude from the University of Texas in Austin, his residency was done at Baylor College of Medicine in Houston, Texas. Dr. Agha completed his Fellowship in Gastroenterology, also at Baylor College of Medicine. He has also published several papers in medical literature pertaining to Gastroenterology.Dr. Agha is a member of the American Gastroenterology Association</a>, Society for Gastrointestinal Endoscopy</a> and the American College of Gastroenterology</a>.". Dr. Agha is rated as an Advanced provider by MediFind in the treatment of Gastric Dysmotility. His top areas of expertise are Familial Adenomatous Polyposis, Gastroesophageal Reflux Disease (GERD), Hiatal Hernia, Endoscopy, and Gastrectomy.
Penn Gastroenterology Limerick
. Dr. Korimilli is rated as an Advanced provider by MediFind in the treatment of Gastric Dysmotility. Her top areas of expertise are Gastritis, Esophagitis, Alcoholic Cirrhosis, Colonoscopy, and Gastrectomy.
Summary: The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.

